Israel’s Can-Fite BioPharma announced positive interim results of its Phase II/III clinical trial of CF101 for the treatment of psoriasis, and is continuing to enrol patients in the study.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000788461&fid=1725
Good news for psoriasis patients
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.